encorafenib 50 MG Oral Capsule [Braftovi]

RxNorm concept 2049117, branded drug (sbd). Prescribable name: BRAFTOVI 50 MG Oral Capsule.

RxCUI: 2049117
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2049117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

encorafenib 2049106

Other names

Braftovi 50 MG Oral Capsule

Related concepts

encorafenib 50 MG (SCDC, consists of)
encorafenib 50 MG [Braftovi] (SBDC, consists of)
Oral Capsule (DF, has dose form)
Braftovi (BN, has ingredient)
encorafenib 50 MG Oral Capsule (SCD, tradename of)

Linked data

NDCs

70255002002

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2049117 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2049117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2049117. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.